Market

Beyond THC and CBD: minor cannabinoids rise

CBN, CBG and others are showing up on more labels. What the 'minor' cannabinoids are about.

A glass dropper lets a golden drop fall into a small amber bottle.
Photo: Cosmin Ursea, Unsplash, Unsplash License

For years, cannabis marketing was all about one number: THC. Lately the conversation has widened, with minor cannabinoids like CBN and CBG appearing on more products and menus.

The newcomers

  • CBN is often marketed around sleep and relaxation, it forms as THC ages.
  • CBG: a non-intoxicating “parent” cannabinoid, is being studied for a range of effects.
  • Products increasingly highlight blends and ratios rather than a single THC figure.

Why now

As the market matures past the “highest THC wins” phase, both producers and informed consumers are paying more attention to a product’s full chemistry, cannabinoids and terpenes together, the entourage effect idea.

A note of caution

The science on minor cannabinoids is still young, and marketing tends to run ahead of the evidence. Treat bold claims (like “CBN = guaranteed sleep”) skeptically. See cannabis and sleep.

A label that talks about more than THC is a sign of a maturing market, just keep your expectations grounded until the research catches up.

Sources

More news

Get the next update by email

A short, plain English email when the law changes or we publish something worth reading.

By signing up, you agree to get the LeafNorth newsletter by email: a short note when cannabis law in Canada changes or when we publish something worth reading. It comes from LeafNorth, hello@leafnorth.ca. You can unsubscribe at any time using the link in every email. How we handle your email.